Clinical studies illustrated how circadian misalignment and sleep restriction were correlated with changes in glucose tolerance and insulin sensitivity, and therefore with a higher risk of developing diabetes and metabolic syndrome [55,56,57,58]. The gene discussed is INS; the disease is metabolic syndrome.